Clinical trial
Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer
NCT01718626 is registered in ClinicalTrials.gov with Hebei Tumor Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer
- Lead sponsor
- Hebei Tumor Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 31, 2012
- Completion date
- December 31, 2014
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer